2162 KYG5252B1023

Rapport

Vertraagde tijd Hong Kong Stock Exchange - 10:08 12-08-2022
32.15	HKD		0.00%

15/06	Keymed Biosciences Inc. Ontvangt subsidies van Center for Drug Evaluation van de National Medical Products Administration voor CM310	CI
10/06	Keymed Biosciences kondigt de toediening aan van de eerste patiënt in de Fase I studie met het bispecifieke antilichaam CM350	CI
20/04	U.S. Food and Drug Administration verleent CMG901 Fast Track aanwijzing als monotherapie voor de behandeling van niet-resectabele of uitgezaaide maagkanker en kanker van de gastro-oesofageale junctie	CI

Nieuws

Andere talen

Officiële publicaties

Sectornieuws

Nieuws in andere talen op KEYMED BIOSCIENCES INC.

07/07	Certain Ordinary Shares of Keymed Biosciences Inc. are subject to a Lock-Up Agreement E..
06/07	Keymed Bio to Subscribe to JP Morgan's Bond Offering
16/06	Keymed Biosciences Obtains Therapy Designation for Antibody Injection
15/06	Keymed Biosciences Inc. Receives Grants from Center for Drug Evaluation of the National..
10/06	Keymed Biosciences Announces Dosing of First Patient in Phase I Trial of Bispecific Ant..
20/04	U.S. Food and Drug Administration Grants CMG901 Fast Track Designation as Monotherapy f..
19/04	US FDA Grants Fast Track Designation to Keymed Bio's Gastric Cancer Drug Candidate
12/04	KeyMed Biosciences Gets US FDA Orphan Drug Designation for Gastric Cancer Drug Candidat..
30/03	Keymed's Chronic Sinusitis Treatment Shows Positive Outcomes in Clinical Trial
30/03	Keymed Biosciences Inc. Announces Phase II Clinical Study of its Self-Developed Class1 ..
29/03	Keymed Biosciences Inc. Announces Executive Changes
29/03	Keymed Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2..
29/03	Keymed Biosciences Inc. Announces Resignation of Dong Lyu as Non-Executive Director
07/03	Keymed has been included as eligible stocks of the Shenzhen-Hong Kong Stock Connect
21/02	Hang Seng Index Adds Lenovo, Nongfu Spring as Constituents; SenseTime, XPeng Admitted t..
18/02	Keymed Bio Joins Hang Seng Family of Indexes
07/01	Certain Ordinary Shares of Keymed Biosciences Inc. are subject to a Lock-Up Agreement E..
03/01	Certain Ordinary Shares of Keymed Biosciences Inc. are subject to a Lock-Up Agreement E..
2021	KEYMED BIOSCIENCES INC.(SEHK : 2162) added to S&P Global BMI Index
2021	Keymed Biosciences Chairman, Controlling Shareholder Ups Stake in Firm
2021	Keymed's Atopic Dermatitis Treatment Shows Positive Results in Clinical Trial
2021	Keymed Biosciences Inc. Announces Positive Results from Cm310 Atopic Dermatitisphase II..
2021	CSPC Pharma Strikes Licensing Deal for China Rights to Keymed Bio's Allergy Drug
2021	Keymed Biosciences' Asthma, Atopic Dermatitis Treatment Gets Positive Results in Phase ..
2021	Keymed Biosciences Inc. Announces Positive Results from Phase I Clinical Study of CM326
2021	KEYMED BIOSCIENCES : Partners With CSPC Pharmaceutical to Develop Potential Nervous System..
2021	KEYMED BIOSCIENCES' : H1 Loss Expands
2021	Keymed Biosciences Inc. Announces Unaudited Consolidated Earnings Result for the Six Mo..
2021	KEYMED BIOSCIENCES : Bio Raises Nearly $58 Million from Full Exercise of Hong Kong IPO's O..
2021	Keymed Biosciences Inc. has completed an IPO in the amount of HKD 3.105498 billion.
2021	Keymed Biosciences Inc. has filed an IPO in the amount of HKD 3.105498 billion.

Komende gebeurtenissen in de sector

27/10/22	GILEAD SCIENCES, INC. : Q3 2022 Cijferpublicaties (schatting)
02/11/22	VERTEX PHARMACEUTICALS INCORPORATED : Q3 2022 Cijferpublicaties (schatting)
03/11/22	WUXI APPTEC CO., LTD. : Q3 2022 Cijferpublicaties (schatting)
07/11/22	BIONTECH SE : Q3 2022 Cijferpublicaties

Meer evenementen

Sector

Gezondheidszorg
	Farmaceutisch en medisch onderzoek
		Biotechnologie & Medisch Onderzoek
			Biotechnologie & Medisch Onderzoek
				Biotherapeutische geneesmiddelen